tiprankstipranks
Trending News
More News >
Neurones (DE:NE9)
:NE9
Germany Market

Neurones (NE9) Technical Analysis

Compare
1 Followers

Summary of all the Indicators

Overall Consensus
Buy
13Bullish
2Neutral
7Bearish
Technical Analysis Consensus
Buy
6Bullish
2Neutral
2Bearish
Moving Average Consensus
Buy
7Bullish
0Neutral
5Bearish
Neurones’s (NE9) Moving Averages Convergence Divergence (MACD) indicator is 0.03, suggesting Neurones is a Sell.
Neurones’s (NE9) 20-Day exponential moving average is 45.03, while Neurones’s (NE9) share price is €45.35, making it a Buy.
Neurones’s (NE9) 50-Day exponential moving average is 45.11, while Neurones’s (NE9) share price is €45.35, making it a Sell.

Neurones (NE9) Pivot Points

Jun 20, 2025, 06:23 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
45.63
46.07
45.63
46.07
45.63
46.07
45.63
Fibonacci
46.07
46.07
46.07
46.07
46.07
46.07
46.07
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Neurones (NE9) Moving Averages

Jun 20, 2025, 06:23 AM
Period
Simple
Exponential
MA5
45.11Sell
45.14Sell
MA10
45.19Sell
45.09Buy
MA20
44.73Buy
45.03Buy
MA50
44.99Buy
45.11Sell
MA100
45.25Sell
44.88Buy
MA200
44.00Buy
43.84Buy
Neurones’s (NE9) 10-Day exponential moving average is 45.09, while Neurones’s (NE9) share price is €45.35, making it a Buy.
Neurones’s (NE9) 100-Day exponential moving average is 44.88, while Neurones’s (NE9) share price is €45.35, making it a Buy.
Neurones’s (NE9) stock price is €45.35 and Neurones’s (NE9) 50-day simple moving average is 44.99, creating a Buy signal.
Neurones’s (NE9) stock price is €45.35 and Neurones’s (NE9) 100-day simple moving average is 45.25, creating a Sell signal.
Neurones’s (NE9) stock price is €45.35 and Neurones’s (NE9) 200-day simple moving average is 44.00, creating a Buy signal.

Neurones (NE9) Technical Indicators

Jun 20, 2025, 06:23 AM
Name
Value
Implied Action
RSI (14)
50.52
Neutral
STOCH (9,6)
-37.75
Buy
STOCHRSI (14)
-4.80
Buy
MACD (12,26)
0.03
Sell
ADX (14)
8.80
Buy
Williams %R
-100.00
Buy
CCI (14)
-59.41
Neutral
ATR (14)
1.26
-
Ultimate Oscillator
1.49
Sell
ROC
1.64
Buy
Neurones’s (NE9) Relative Strength Index (RSI) is 50.52, creating a Neutral signal.
Neurones’s (NE9) Trend Strength Indicator (ADX) is 8.80, creating a Buy signal.
Neurones’s (NE9) Commodity Channel Index (CCI) is -59.41, creating a Neutral signal.
Neurones’s (NE9) Price Rate of Change (ROC) is 1.64, creating a Buy signal.

FAQ

Is NE9 a Buy, Hold, or Sell?
Based on NE9’s technical indicators, NE9 is a Buy.
    What is NE9’s RSI (14)?
    NE9’s RSI (14) is 50.52, which suggests NE9 is a Neutral.
      What is NE9’s MACD?
      NE9’s MACD is 0.03, which suggests NE9 is a Sell.
        What is NE9’s 5-day moving average?
        NE9’s 5-day moving average is 45.11, which suggests NE9 is a Sell.
          What is NE9’s 20-day moving average?
          NE9 20-day moving average is 44.73, which suggests NE9 is a Buy.
            What is NE9’s 50-day moving average?
            NE9’s 50-day moving average is 44.99, which suggests NE9 is a Buy.
              What is NE9’s 200-day moving average?
              NE9’s 200-day moving average is 44.00, which suggests NE9 is a Buy.
                What is NE9’s Williams % R (14)?
                NE9’s Williams % R (14) is -100.00, which suggests NE9 is a Buy.
                  What is NE9’s CCI (14)?
                  NE9’s CCI (14) is -59.41, which suggests NE9 is a Neutral.
                    What is the share price of Neurones?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis